Plasma Amino-Terminal B-Type Natriuretic Peptide Measured by Elecsys 2010 Assay in a Trial of Hormone-guided Treatment for Heart Failure
- 1 July 2003
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 49 (7), 1212-1215
- https://doi.org/10.1373/49.7.1212
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart FailureNew England Journal of Medicine, 2002
- The Prognostic Value of B-Type Natriuretic Peptide in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 2001
- Effect of Carvedilol on Survival in Severe Chronic Heart FailureNew England Journal of Medicine, 2001
- Plasma amino-terminal pro-brain natriuretic peptide: A novel approach to the diagnosis of cardiac dysfunctionJournal of Cardiac Failure, 2000
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Validating aminoterminal BNP assays: a word of cautionThe Lancet, 1999
- Development of a novel, N-Terminal-proBNP (NT-proBNP) assay with a low detection limitScandinavian Journal of Clinical and Laboratory Investigation, 1999
- Immunoreactive amino‐terminal pro‐brain natriuretic peptide (NT‐PROBNP): a new marker of cardiac impairmentClinical Endocrinology, 1997
- The Amino-Terminal Portion of Pro-Brain Natriuretic Peptide (Pro-BNP) Circulates in Human PlasmaBiochemical and Biophysical Research Communications, 1995
- Assay of brain natriuretic peptide (BNP) in human plasma: evidence for high molecular weight BNP as a major plasma component in heart failureJournal of Clinical Endocrinology & Metabolism, 1993